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Langerin, an endocytic receptor of Langerhans cells, binds
pathogens such as human immunodeficiency virus by recognition
of surface glycoconjugates and mediates their internalization into
Birbeckgranules.Langerinhasanextracellularregionconsistingof
a C-type carbohydrate-recognition domain (CRD) and a neck
regionthat stabilizes formationof trimers.As inmanyotherC-type
lectins, oligomerization is required for high affinity binding to gly-
can ligands and is also likely to be important for determining spec-
ificity. To facilitate structural analysis of the human langerin tri-
mer, a truncated formof the extracellular region, consistingof part
of the neck and the CRD, has been characterized. Like the full-
length protein, truncated langerin exists as a stable trimer in solu-
tion.Glycan array screeningwith the trimeric fragment shows that
high mannose oligosaccharides are the best ligands for langerin.
Structural analysis of the trimeric fragment of langerin confirms
that theneckregionformsacoiled-coilof-helices.Multiple inter-
actions between the neck region and the CRDs make the trimer a
rigid unit with the three CRDs in fixed positions and the primary
sugar-binding sites separated by a distance of 42 A˚. The fixed ori-
entation of the sugar-binding sites in the trimer is likely to place
constraints on the ligands that can be bound by langerin.
Langerin (CD207), a C-type lectin of Langerhans cells, binds
pathogens, including Candida albicans and human immunod-
eficiency virus (HIV),2 through recognition of surface glyco-
conjugates containingmannose or related sugars (1–4). Lange-
rin is an endocytic receptor associated with formation of
Birbeck granules, subdomains of the endosomal compartment
specific to Langerhans cells (3–6). Glycoconjugate ligands
internalized via langerin are degraded, and it is likely that lan-
gerin plays a role in antigen processing and presentation, the
main function of Langerhans cells. Langerin can mediate
uptake and processing of antigens for presentation by both
major histocompatibility class I and class II molecules and has
also been implicated in the processing of mycobacterial non-
peptide antigens for presentation by CD1a (7, 8). Langerin can
prevent transmission ofHIV fromLangerhans cells to T cells by
mediating internalization and degradation of the virus (9, 10).
Langerin is a type II transmembrane protein with an extra-
cellular region consisting of a neck and a C-terminal C-type
carbohydrate-recognition domain (CRD) (3, 4). Like many
other C-type lectins, langerin exists as an oligomer, forming
trimers stabilized by a coiled-coil of-helices in the neck region
(11). Trimer formation is essential for binding to oligosaccha-
ride ligands because, as is typical for C-type CRDs, the CRD of
langerin has only low affinity for monosaccharides (11, 12).
Oligomerization of C-type lectins is also important for deter-
mining selectivity for particular oligosaccharide structures. For
example, in serummannose-binding protein, threeCRDs in the
trimeric unit are held in a fixed position via interactions
between the CRDs and an -helical neck region so that the
binding sites are arranged to interact with arrays of sugars in
polysaccharides of bacterial cell walls, but not withmammalian
high mannose-type oligosaccharides (13). In contrast, CRDs in
the tetramer of the dendritic cell receptor DC-SIGN and in the
related receptor DC-SIGNR have a more flexible arrangement,
which allowsmovement of the CRDs in the tetramer relative to
each other to facilitate engagement of multiple ligands with
variable spacing such as the high mannose-type oligosaccha-
rides of gp120 on the surface of HIV (14, 15).
Crystal structures of the CRD of human langerin in complex
with mannose or maltose show that it binds monosaccharides
by ligation to a bound Ca2 at a site that is conserved in all
C-type CRDs (16). Interestingly, the co-crystals also show the
presence of a second sugar-binding site that has not been seen
in other C-type lectins. Both monosaccharide residues of malt-
ose, or the monosaccharide mannose, are bound in this second
site largely via polar interactions with backbone residues in a
cleft formed between two of the large loop regions in the top
half of the domain (16). This cleft is wider in langerin than in
other C-type CRDs, most likely due to the absence of auxiliary
Ca2 sites present in many other CRDs, including those of
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mannose-binding protein and DC-SIGN (17, 18), and is also
more flexible (see below). Modeling studies suggest that high
mannose oligosaccharides such asMan9 could bind to langerin
through ligation of the terminalmannose residue of one branch
toCa2 at the primary sugar-binding site and interaction of two
mannose residues of another branch at the secondary site (16).
Computational docking of linear three mannose fragments of
Man9, Man1,2Man1,2ManOMe, and Man1,2Man1,
3ManOMe correlates well with the two binding sites found in
the structure of theCRDcomplexedwithmannose andmaltose
and suggests that the mannose bound to the Ca2 in the pri-
mary binding site is the central mannose with 3-OH and 4-OH
coordinating the Ca2 (19).
An elongatedmodel for the extracellular domain of langerin,
constructed using the trimeric structure of mannose-binding
protein and the -helical bundle of the influenza virus hemag-
glutinin trimer, was found to have good correlationwith hydro-
dynamic measurements (19). This model was used to interpret
the organization of langerin in electronmicrographs of Birbeck
granules. However, the model is limited in its ability to predict
details that can influence the selectivity of langerin toward dif-
ferent carbohydrates, such as possible rigidity or flexibility of
the hinge between the neck and the CRD, or the precise dis-
tance between CRDs in the oligomer. Because the affinity of
langerin is enhanced by oligomerization, an experimental
structure of the trimer is important for understanding its selec-
tivity for particular oligosaccharides or certain patterns of sugar
presentation and is more broadly useful for understanding dif-
ferences in the binding selectivity among the various C-type
lectins that have similar oligosaccharide specificities in the
monomeric form.
In this paper, the crystal structure of a trimeric fragment of
langerin consisting of the CRDs and part of the neck domain is
reported. The structure shows that multiple interactions
between the neck region and the CRDs make the trimer a rigid
unit with the CRDs in fixed positions and the primary sugar-
binding sites separated by a distance of 42 Å. As in mannose-
binding protein, the fixed orientation of the sugar-binding sites
in the trimer is likely to place constraints on the ligands that can
be bound by langerin.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification—DNA coding for a frag-
ment of the extracellular domain of human langerin from resi-
due 148 in the neck region to the C terminus (designated “trun-
cated langerin”) was cloned into the pT5T expression vector
using appropriate restriction sites and a synthetic oligonucleo-
tide designed to bridge the end of the coding sequence and the
BamHI site of the vector. The resulting plasmid was trans-
formed into Escherichia coli strain BL21/DE3. Growth and
induction of bacteria, and extraction and purification of protein
on mannose-Sepharose were as described previously for the
full-length extracellular domain of langerin (11).
Analytical Ultracentrifugation—Sedimentation equilibrium
analysis was carried out in a Beckman Optima XL-A analytical
ultracentrifuge using an An60Ti rotor at 20 °C. Truncated lan-
gerin at 0.2 mg/ml in 25 mM Tris-HCl, 0.15 M NaCl, 2.5 mM
CaCl2 was analyzed at 10,000 rpm and 20,000 rpm. Data were
analyzed using UltraSpin software developed by Dmitry
Veprintsev.
GlycanArrayAnalysis—Truncated langerinwas labeledwith
fluorescein by dialysis into 100mMbicine (pH9.0), 0.15MNaCl,
5 mMCaCl2 and incubation with fluorescein isothiocyanate (50
g/mg protein) overnight. Labeled protein was isolated by
affinity chromatography on a 1-ml column of mannose-Sepha-
rose. Fluorescein-labeled truncated langerin was used to probe
version 3.2 of the glycan array following the standard procedure
of Core H of the Consortium for Functional Glycomics.
Crystallization and Data Collection—Crystals of truncated
langerin were obtained by hanging-drop vapor diffusion, with
0.5l of protein plus 1l of reservoir in a drop. All crystals were
grown at 22 °C. Form 1 crystals were grown from a protein
solution comprising 10mg/ml langerin, 9mMCaCl2, 9 mMTris
(pH 7.8), 22.5 mMNaCl, and 100mM D-mannose. The reservoir
solution contained 8% polyethylene glycol (PEG) 8000, 0.1 M
imidazole (pH 8.5), and 0.2 MCa(CH3COO)2. The crystals were
dehydrated by serial transfer to fresh reservoir solution con-
taining increasing percentages of PEG 8000: 16% for 24 h; 24%
for 24 h, then to 32% for 48 h. The crystals were then frozen in
liquid nitrogen for data collection.
Form 2 crystals were grown from a protein solution compris-
ing 10 mg/ml langerin, 10 mM Tris (pH 8.0), and 25 mM NaCl.
The reservoir solution contained 15% PEG 3350 and 0.2 M
NH4Cl. Crystals were transferred to a fresh reservoir solution
containing 35% PEG 3350, andwere then frozen in liquid nitro-
gen for data collection.
Diffraction data weremeasured at 100 K on beamline 11-1 of
the Stanford Synchrotron Radiation Lightsource. Data were
processed with MOSFLM and SCALA (20) and are summa-
rized in Table 1.
Structure Determination—The form 1 crystals were solved to
a resolution of 4.0 Å by molecular replacement phasing, using
coordinates of the langerinCRD (residues 197–326Ca2 and
mannose; Protein Data Bank (PDB) code 3BC7) as a search
model. Self-rotation functions indicated the presence of 4-fold
and 3-fold noncrystallographic rotational symmetry.Molecular
replacement was performed using the program Phaser (21),
searching for one monomer at a time while fixing those previ-
ously placed. After eight CRDs were located, it was noted that
several pairs of CRDs had a relative rotation of 120°, and their N
termini were sufficiently close to one another to likely be part of
a trimer. This axis corresponded to the noncrystallographic
3-fold axis observed in self-rotation functions. Assuming a
closed 3-fold symmetry for each trimer, the third copywas gen-
erated tomake a trimer of CRDs. This trimermodel was used in
a second round of Phaser, this time searching for eight trimers.
To save time, this run was manually interrupted after four tri-
mers were placed, and the other four trimers were generated
using NCS operations to give eight trimers (24 monomers),
arranged in the P1 unit cell with 432 noncrystallographic sym-
metry. Rigid body refinement (50–4 Å) gave r 44.2%, Rfree
44.6%using the trimers as eight rigid groups, and further refine-
ment using the 24 individual CRDs as rigid bodies gave
r  39.1%, Rfree  39.3%. No further refinement was done for
these data because a higher resolution data set from the form 2
crystals was obtained at that time.
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The higher resolution form 2 crystal structure was solved by
molecular replacement, using the program COMO (22). The
searchmodel comprised a single trimer of CRDs from the form
1 crystal solution, using data in the resolution range 12–3.5 Å.
Two trimers were found in the asymmetric unit. The final cor-
relation coefficient was 39%, and the R value was 41%. Model
building and refinement were performed with Coot (23) and
Phenix (24). In the initial stages of refinement, noncrystallo-
graphic symmetry constraints were imposed but were released
in later stages as the electron density maps indicated that the
neck of the CRDs does not adopt the same symmetry relation-
ships as the CRDs (see below). Refinement included individual
positional and temperature factor refinement with translation-
libration-screw modeling. For translation-libration-screw
refinement, each chain was split into two domains, the CRD
and the oligomerization domain, to give a total of 12 groups.
Although no Ca2 was present in the crystallization buffer, it
was present during protein purification. Strong electron den-
sity (6 in Fo  Fc maps) was visible at the known Ca2 site
and was therefore modeled as such. All analysis presented here
is based on the refined form 2 crystals.
RESULTS ANDDISCUSSION
Glycan Binding by a Trimeric Fragment of Langerin Extracel-
lular Domain—To facilitate structural analysis of the trimeric
extracellular domain of langerin, a truncated form of human
langerin was produced. Truncated langerin corresponds to a
proteolytic fragment seen in preparations of the full-length
extracellular domain and consists of the last seven heptad
repeat sequences (including a 4-residue deletion in the pat-
tern; see below) of the neck region together with the CRD
(Fig. 1A). Truncated langerin has better solubility properties than
the full-length extracellular domain. Sedimentation equilibrium
analytical ultracentrifugation was used to confirm that truncated
langerin forms a stable trimer, like the full-length extracellular
domain,with ameasuredMr of 62,530 comparedwith the value of
61,833 predicted for a trimer (Fig. 1B).
The binding specificity of truncated langerin was investi-
gated by screening the glycan array of theConsortium for Func-
tional Glycomics. Oligosaccharide-binding specificity of lange-
rin has been studied previously by screening a smaller array of
oligosaccharides and glycoproteins with an IgG-Fc chimera of
the extracellular domain of mouse langerin, but analysis of the
native trimeric structure has not been reported (25). At a rela-
tively high concentration of fluorescein-labeled truncated lan-
gerin, binding to four types of oligosaccharide ligands is
observed: high mannose oligosaccharides, structures with ter-
minal GlcNAc residues, structures with terminal fucose resi-
dues, and structures with terminal 6-sulfated galactose residues
(Fig. 2). Ligands giving the highest signals are Man9 (oligosac-
charide number 311), Gal1–3(Fuc1–2)Gal (blood group B
FIGURE 1. Characterization of a trimeric fragment of human langerin.
A, diagramshowingdomainorganizationof full-length langerin and the trun-
cated langerin construct. The starting and final amino acid residues are indi-
cated, with numbering based on the residue numbers of full-length langerin.
B, sedimentation equilibrium analysis of truncated langerin. A scan of a sam-
ple after 24 h at 10,000 rpm is shown.
TABLE 1
Crystallographic data statistics
Data collecton SSRL 11-1 Data set 1 Data set 2
Space group P1 P21
Unit cell lengths (Å) a 119.8 a 80.8
b 120.0 b 77.5
c 120.7 c 85.9
Angles (°)  90.2  94.4
 106.5
 95.2
Resolution Å (last shell) 119.5-4.0 (4.22-4.0) 85.7-2.3 (2.42-2.3)
Rsym (last shell) 4.5 (16.4) 7.9 (34.0)
Mean ((I)/S.D.(I)) 12.6 (4.6) 11.2 (4.2)
% Completeness (last shell) 94.6 (95.8) 99.6 (99.1)
Average multiplicity (last shell) 2.0 (2.0) 3.7 (3.7)
Refinement Data set 2
Resolution for refinement
(last shell)
48.0-2.30 (2.35-2.30)
Residues included in final model A 159:327 B 167:259 262:325
C 167:325 D 166:259 263:326
E 167:326 F 165:326
6 Ca2 407 H2O
Rfreea 23.8 (29.5)
Ra 18.2 (23.0)
Average B factor 41.9
Bond length r.m.s.d.b 0.005
Angle r.m.s.d. 0.82
Ramachandran plot (% in
preferred/allowed/
outliers regions)c
95.8/4.1/0.1
aRsym  hi(Ii(h)  I(h))/hiIi(h) where Ii(h)  observed intensity, and
I(h)  mean intensity obtained from multiple measurements. R and Rfree 
 FoFc/Fo, where Fo  observed structure factor amplitude and Fc 
calculated structure factor amplitude for the working and test sets, respectively.
b r.m.s.d, root mean square deviation.
c As defined in Coot.
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antigen; oligosaccharide number 287), Man5 (oligosaccharide
number 195), and 6-O-SO3Gal1–4(6-O-SO3)GlcNAc (oligo-
saccharide number 285).
Binding to oligosaccharides with terminal mannose, fucose,
orGlcNAc residues is consistentwith the specificity of theCRD
of langerin for these monosaccharides (11). There is, however,
some selectivity for particular structures bearing these residues.
In most of the fucose-terminated glycans on the array that are
bound by langerin, fucose is linked 1,2 to galactose, although
not all structures with 1,2-linked fucose are bound. Also,
unlike DC-SIGN and the scavenger receptor C-type lectin, lan-
gerin does not bind to glycans containing the LewisX structure:
Gal1–4(Fuc1–3)GlcNAc (26, 27). All of the GlcNAc-
terminated structures bound by langerin contain GlcNAc
linked to galactose or GalNAc, and no binding is seen to struc-
tures terminating in GlcNAc1,2Man. Langerin thus differs
from the liver endothelial cell C-type lectin LSECtin, which
binds with high specificity to structures with terminal
GlcNAc1,2Man (28). Lack of bind-
ing of human langerin to structures
containing LewisX is consistentwith
studies showing that transfected
cells expressing langerin did not
bind beads coated with LewisX and
that LewisX did not inhibit binding
of HIV gp120 to these cells (10).
Screening the glycan array at a 4-
fold lower concentration of labeled
langerin gives an indication of rela-
tive affinities of langerin for the dif-
ferent structures. At the lower con-
centration of langerin the only
binding detected is to highmannose
oligosaccharides, to a few structures
with terminal 6-sulfated galactose
residues, and to the blood group B
antigen. No binding to other struc-
tures with terminal fucose residues
or to anyGlcNAc-terminated struc-
tures is detected, suggesting that
these oligosaccharides are only low
affinity ligands for langerin. The
highest signals are again given by
Man9 and other high mannose oli-
gosaccharides, indicating that these
glycans are likely to be the best
ligands for langerin.
Binding to oligosaccharides with
6-sulfated galactose residues, aswell
as to high mannose structures, was
demonstrated previously for the
IgG-Fc chimera of mouse langerin
(25). It is not clear how sulfated
galactose is bound by langerin as
monosaccharides with an axial
4-hydroxyl group would not be
expected to fit into the primary
binding site of the mannose-type
CRD, which binds sugars with equatorial 3 and 4 hydroxyl
groups (11). Langerin does not bind to galactose, so interactions
with the sulfate group must contribute significantly to binding
of sulfated galactose. There is specificity to these interactions
because both mouse and human langerin bind to ligands with
terminal 6-sulfated galactose but not to those with galactose
sulfated at the 3 position (25). It is possible that 6-sulfated galac-
tose binds to langerin in the secondary binding site identified in
the CRD (16).
Structure of Langerin Trimer—To visualize the arrangement
of CRDs in the langerin trimer, the trimeric fragment used in
the glycan-binding studies was crystallized, and the structure
determined at 2.3 Å (Table 1 and Fig. 3). There are two trimers
in the asymmetric unit, comprising chains A, B, and C (trimer
1) and D, E, and F (trimer 2). Residues 167–325 are visible in all
six crystallographically independent protomers, except that
residues 260–261 are absent in copy B and 260–262 in copy D.
Additional N-terminal residues are seen in some copies (see
FIGURE 2. Binding of fluorescently labeled truncated langerin to a glycan array. The ligands giving the
highest signals are identified. Green bars indicate high mannose structures. Red bars indicate structures with
terminal fucose residues. Blue bars indicate structureswith terminal GlcNAc. Purple barsdenote structureswith
terminal 6-sulfatedgalactose residues. Thedata shown represent themeanof four replicates. Numerical values
with standard deviations as well as a full list of glycans on the array are available in supplemental Table 1.
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below). The CRDs deviate slightly from perfect 3-fold symme-
try, with protomers A and B superimposing at a relative rota-
tion angle of 122.9°, and A and C superimposing at an angle of
119.6°; similar deviations are observed in the second crystallo-
graphically independent trimer.With the exception of a loop at
residues 258–262, the CRDs are virtually identical in structure
(see below).
The neck sequence is composed of series of heptad repeats.
As expected, the visible portion of the neck, residues 167–199,
is all-helical through residue Ser196. There is a “stammer” (29)
corresponding to a deletion of 4 residues in the normal heptad
repeat near residue 167, giving rise to a pattern of hydrophobic
residues starting at residue 157 of …d-a-a-d-a-d… (i.e. hydro-
phobic residues spaced 4-3-3-4-3 instead of 4-3-4-3-4-3) (Fig.
4A). This sequence irregularity correlates with the loss of elec-
tron density N-terminal to residue 167, suggesting that it is a
point of flexibility. Only protomerA is visible starting at residue
159, but this can be ascribed to contactswith a crystal symmetry
mate. Of the five other neck regions in the asymmetric unit, one
starts from residue 165, one from residue 166, and three from
residue 167. Flexibility or rotation in the region prior to the
visible N termini is likely required because modeling of longer
helices indicates that residues N-terminal to those observed in
the electron density would not contact one another.
The neck also displays a pronounced curvature that causes a
deviation from the symmetry of the CRDs. Protomers in the
C-terminal part of the neck, close to the beginning of the CRD,
superimpose on one another with rotational relationships sim-
ilar to those of the CRDs, indicating a fixed, rigid relationship
between the neck andCRD.However, the neck starts to diverge
toward the N-terminal section, where it twists with respect to
the C-terminal portion (Fig. 4). This can be seen by dividing the
visible portion of the neck into N- and C-terminal segments,
spanning residues 167–184 and 185–195. Protomers in the
C-terminal region were superimposed, and this transformation
was applied to the entire neck. Then, theN-terminal portions of
the neck were superimposed. A rotation of the helix of 8.3° was
needed to superimpose the N-terminal region of helix B onto
the corresponding portion of helix A, and a rotation of 8.2° was
needed to superimpose the N-terminal region of helix C onto
helix A.
Interactions Stabilizing the Trimer and Positioning the
CRDs—Interactions between four regions of the protein con-
tribute to oligomerization of the trimer and setting the position
of the CRDs: (i) interhelical contacts within the neck; (ii) con-
tacts between the end of the neck domain of one protomer and
the CRD of another; (iii) contacts between adjacent CRDs; and
(iv) contacts between the neck domain and the CRD within a
protomer. Because the CRD is a monomer without the neck
domain (11), it can be concluded that the neck is necessary for
oligomerization but that the other interactions seen in the tri-
mer structure, both between CRDs and between the neck
domain of onemonomer and theCRDof another, contribute to
oligomerization and also influence the spacing between the
CRDs. The positioning of one CRD relative to another is also
influenced by the interactions between the neck and CRD
FIGURE 3. Diagram of the overall structure of truncated langerin. A, sec-
ondary structureofprotomerA.-Helices are shown in red,-sheets in yellow,
loops in green. Ca2 is shown as a blue sphere. B, top view of the trimer struc-
ture. Protomer A is shown in yellow, B inmagenta, and C in cyan. C, side view
of the trimer.
FIGURE 4. Neck structure and deviation from 3-fold symmetry.
A, sequence of the neck domain of truncated langerin. The amino acid
sequence numbers are marked on top, and the heptad repeat numbering is
on the bottom. Residues 1 and 4 of each heptad repeat are highlighted; those
highlighted in yellow are visible in all crystallographically independent copies.
The box indicates the visible portion of protomer A. B, superposition of pro-
tomerBCRD residues 200–257and263–325ontoA is shown in light gray, and
C onto A is in dark gray. Protomers A, B, and C are shown in yellow,magenta,
and cyan, respectively. Note that when protomer B or C is superimposed on
protomer A, the remaining protomer does not superimposewell as a result of
the deviation from perfect 3-fold symmetry. C, flexibility in the neck region
revealed by the same superpositioning as in panel B but showing only pro-
tomer A in yellow, protomer B superimposed on A in light gray, and protomer
C superimposed on protomer A in dark gray. When only the CRDs are super-
imposed, the N-terminal part of the neck does not superimpose well.
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within one monomer. Collectively, these interactions make the
trimer a rigid unit, so it is not surprising that the two crystal-
lographically independent trimers display similar spacings
of their CRDs. Moreover, rigid-
body refinement of the lower res-
olution crystal form (see “Ex-
perimental Procedures”; data not
shown) indicates that the CRDs
in the eight crystallographically
independent trimers in that crys-
tal lattice also have the same spac-
ing of CRDs. The following analy-
sis was performed on the trimer
designated by chains A, B, and C in
the coordinates, but similar inter-
actions are present in the other
trimer.
As expected, nonpolar packing
interactions occur between hydro-
phobic residues at the a and d
positions of the heptad repeats
(Fig. 5A). The only exception is
Gln188, which is a d position. The
side chain from each copy points
toward the 3-fold axis, and there is
electron density, presumably a
water molecule but possibly Na, on the 3-fold axis within
hydrogen-bonding distance of the side chains. If this is a
water molecule, then there would be a statistical average of
FIGURE 5. Interactions stabilizing the trimer andpositioning the CRDs. Protomer A is shown in yellow, B inmagenta, and C in cyan. A, interactions between
theneck regions. Left, topview.Right, side view.B, interactionsbetween theendof theneckdomainof onemonomer and theCRD fromanothermonomer. Left,
overall view with a box showing the area where the interactions take place. Right, expanded view of the box on the left. C, interactions between CRDs. Left,
overall view with a box showing the area where the interactions take place. Right, expanded view of the box on the left. D, neck to CRD interactions in one
monomer. Left, overall position of the interactions between the neck domain and the CRD. Right, close up view showing only monomer A. Helices are shown
in red, -strands in yellow, loops and carbon atoms in green, oxygen atoms in red, and nitrogen atoms in blue.
FIGURE 6. Flexibility of the loop region comprising residues 258–262. A, superposition of the CRD in chain
B onto the CRD in chain A, in light gray, and chain C onto chain A, in dark gray. Chain A of truncated langerin is
shown in yellow. B, superposition of themannose-CRD complex structure, PDB 3BC7, on the CRD of truncated
langerin protomer A. The box indicates the largest difference. C, close up view of the superposition shown in B.
Note that in both this superposition as well as those of the different copies of the CRD within the trimer
described here, the biggest change is in residues 258–262, which form the loop between -strand 2 and
-strand 2 (Fig. 3) in the vicinity of the secondary sugar-binding site.
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two-thirds of the side chains with either the carbonyl oxygen
or amide nitrogen facing the water molecule. In addition,
there are several interactions between the loop that connects
the neck helix to the CRD with the -strand 0 and -helix 2
of a neighboring CRD (Fig. 5B). Gly198 (chain A) packs
against the side chain of Lys200 (chain B), Ser196 (A) packs
against Tyr201 (B), and Gln197 (A) packs with Phe241 (B).
There are also hydrogen bonds formed between the main
chain of Ser196 (A) and Tyr201 (B) (Fig. 5B). The trimer is
further stabilized by inter-CRD interactions: -helix 1 and
the preceding loop of one protomer contact -helix 2 and the
loop that follows it in the neighboring CRD. Specifically,
Leu211 and Ile212 (chain A) pack against Leu249, Gly247, and
Gly248 (chain B), and Arg226 (A) packs against the side chain
and also forms a hydrogen bond with the main-chain car-
bonyl hydrogen of residue Lys244 (B) (Fig. 5C).
The interactions between the neck and CRDwithin one pro-
tomer involve residues from the -helical neck and residues
from the loop prior to -strand 0, -strand 1, and the C-termi-
nal part of the CRD that follows -strand 5 (Fig. 5D). The loop
before -strand 0, comprising residues 197–199, is involved in
both hydrogen bond and packing interactions with residues
from the C-terminal part of the neck helix (residues 193–195).
The side chain of Tyr201 in -strand 0 packs against the side
chain of Ile191 and also hydrogen bonds to Arg187. The side
chain of Phe206, which is part of -strand 1, is packed against
FIGURE 7. Oligomers of C-type lectins. A, truncated langerin. The spacing shown is the average of the distances. B, human mannose-binding protein, PDB
1HUP. The trimer was generated by applying crystallographic symmetry. C, rat mannose-binding protein, PDB 1RTM. The spacing shown is the average of the
distances.D, human lung surfactant protein D, PDB 1PW9. E, surfactant protein A, PDB 1R13. The trimerwas generated by applying crystallographic symmetry.
F, DC-SIGNR, dimer structure, PDB 1SL6. The dimer was completed by applying crystallographic symmetry. G, DC-SIGNR tetramer structure, PDB 1XAR. The
tetramer was generated by applying crystallographic symmetry. The spacing for this model was by calculated by measuring the distance between Na
occupying the positions of the Ca2.
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the side chain of Val194 and the C of Ile191. Tyr323, positioned
at theC-terminal part of theCRD, packsC ofAsp190 andC of
Arg187 and forms a hydrogen bond with the side chain of
Asp190. Ser326, near the C terminus of the CRD, further sets the
position of the CRD by a hydrogen bond to Asp190. The side
chains of Tyr323, Phe206, Tyr201, and Trp199 from the CRD
together with the side chains of Ile191 and Val194 of the neck
pack to form a hydrophobic pocket in between the two
domains. This pocket is buried between the two domains,
locked by hydrogen bond interactions between Asp190 and
Arg187 from the neck and Tyr201, Tyr323, and Ser326 from the
CRD (Fig. 5D).
The langerin trimer structure differs in significant ways
from the mannose-binding protein trimer used to generate
computational models of langerin (19). This is due princi-
pally to the differences imparted to the neck-CRD interac-
tions by the extension at the N terminus of the CRD provided
by 0 and surrounding residues. These differences result in
different CRD-CRD interfaces within the trimer, although
the rigidity of the trimer observed in the different crystallo-
graphic copies is reminiscent of mannose-binding protein.
Flexibility of the Loop Region Forming a Secondary Sugar-
binding Site—In the previously reported structure of themono-
meric langerin CRD bound tomannose ormaltose, sugars were
bound to the conserved principal Ca2-binding site in a mode
similar to other mannose-type ligands bound to the C-type
CRD. A surprising feature, however, was a second, Ca2-inde-
pendent binding site formed by the loop at residues 258–262
(16). In the present structure, the only significant deviation
among the CRDs occurs in this loop: if this loop is omitted
from the superposition, the root mean square deviation is
0.26 Å for the C positions of CRDs of chains A and B and
0.30 Å between chains A and C. The 258–262 loop adopts
different conformations in different protomers (Fig. 6), and
the various conformers are stabilized by contacts with other
trimers in the crystal lattice. These observations indicate
that the loop is flexible, and formation of the crystal lattice
selects various low energy conformations from the ensemble
in solution. One of these conformations is similar to that
observed bound to mannose, whereas the other would
occlude mannose from the site. Presumably, the bound sugar
stabilizes this otherwise flexible loop.
Fixed Orientation of the Primary Sugar-binding Sites in the
Trimer—Oligomerization confers high avidity binding to
C-type lectins. In some cases, for example, mannose-binding
protein, the CRDs are held in fixed positions, which allows
them to bind avidly only to dense, repetitive arrays of sugars on
target cells while binding only weakly to the more closely
spaced terminal sugars on host glycans (13) (Fig. 7). In other
cases, for example, DC-SIGN, the CRDs are linked flexibly to
the oligomerization domain (14) (Fig. 7), allowing them to
adapt and bind avidly to glycans displaying a broader range of
spacings. The structural data presented here indicate that the lan-
gerin CRDs are held in a fixed orientation, with their principal
carbohydrate-binding sites (definedas thepositionof theprincipal
Ca2) spaced42Å fromone another. This is similar to the fixed
spacing of CRDs in human mannose-binding protein. Unlike
mannose-bindingprotein, langerin canbindpreferentially to clus-
ters of mannose in high mannose N-linked oligosaccharides, but
this is a property intrinsic to the CRD rather than the oligomeric
structure. The wide, fixed spacing of the langerin CRDs indicates
that avidity enhancements due to binding ofmultipleCRDsmight
occur only for certain classes ofmultiply glycosylated glycoprotein
orcell surface ligands,which likely contributes to the specificity for
particular pathogens.
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